Tomas Navratil
11Patents
5h-index
31Co-inventors
62Inventor score
Filing activity: Jun 26, 2009 → Jul 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8207195B2 | Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds | Human Necessities | 36 | Active |
| US8299096B2 | Method for treating pulmonary diseases using rho kinase inhibitor compounds | Chemistry; Metallurgy | 30 | Active |
| US8410147B2 | Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds | Emerging Cross-Sectional Technologies | 28 | Active |
| US8945605B2 | Aerosol delivery systems, compositions and methods | Emerging Cross-Sectional Technologies | 10 | Active |
| US10849656B2 | Implant applicators and methods of administering implants | Human Necessities | 8 | Active |
| US8778383B2 | Methods of treatment | Human Necessities | 5 | Active |
| US10624904B2 | Intravitreal drug delivery systems for the treatment of ocular conditions | Human Necessities | 1 | Active |
| US10335558B2 | Methods of treatment | Human Necessities | 1 | Active |
| US11116776B2 | Intravitreal drug delivery systems for the treatment of ocular conditions | Human Necessities | 1 | Active |
| US11406596B2 | Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions | Chemistry; Metallurgy | 0 | Active |
| US12285596B2 | Implant applicators | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.